Authors: KARLSSON MO SWEDBERG K SCHAEFER HG WILTSE C MCNAY J

Citation: Mo. Karlsson et al., POPULATION PK PD MODELS OF MOXONIDINE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE/, Clinical pharmacology and therapeutics, 63(2), 1998, p.

Authors: WAAGSTEIN F MOBINI R ANDERSSON B BERGH CH FU MLX MCNAY J

Citation: F. Waagstein et al., MOXONIDINE ATTENUATES TRANSMYOCARDIAL NOREPINEPHRINE CONCENTRATION GRADIENT AND TOTAL-BODY NOREPINEPHRINE SPILLOVER IN CONGESTIVE-HEART-FAILURE, Circulation, 98(17), 1998, pp. 4091-4091

Authors: DICKSTEIN K KOPP U MANHENKE C AARSLAND T WAAGSTEIN F MOBINI R MCNAY J

Citation: K. Dickstein et al., THE HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF MOXONIDINE, A SYMPATHETICINHIBITOR, IN CONGESTIVE-HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7275-7275

Authors: SWEDBERG K WAAGSTEIN F DICKSTEIN K WILTSE C MCNAY J

Citation: K. Swedberg et al., MOXONIDINE, A CENTRALLY ACTING SYMPATHETIC INHIBITOR, CAUSES SUSTAINED REDUCTION OF PLASMA NOREPINEPHRINE IN HEART-FAILURE PATIENTS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7625-7625

Authors: JUULMOLLER S SWEDBERG K DICKSTEIN K MCNAY J

Citation: S. Juulmoller et al., MOXONIDINE IMPROVES HEART-RATE-VARIABILITY IN PATIENTS WITH HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 99656-99656